{"organizations": [], "uuid": "085e9bed5b9270d0208b150cf886861931c64798", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-oncobiologics-q1-loss-per-share-07/brief-oncobiologics-q1-loss-per-share-0-71-idUSASB0C5P0", "country": "US", "domain_rank": 408, "title": "BRIEF-Oncobiologics Q1 Loss Per Share $0.71", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-02-14T22:22:00.000+02:00", "replies_count": 0, "uuid": "085e9bed5b9270d0208b150cf886861931c64798"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-oncobiologics-q1-loss-per-share-07/brief-oncobiologics-q1-loss-per-share-0-71-idUSASB0C5P0", "ord_in_thread": 0, "title": "BRIEF-Oncobiologics Q1 Loss Per Share $0.71", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "oncobiologics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 22 PM / in 13 minutes BRIEF-Oncobiologics Q1 Loss Per Share $0.71 Reuters Staff * ONCOBIOLOGICS REPORTS FIRST QUARTER FISCAL YEAR 2018 RESULTS * Q1 LOSS PER SHARE $0.71 * Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.20 * CASH WAS $13.8 MILLION AS OF DECEMBER 31, 2017, COMPARED TO $3.2 MILLION AS OF SEPTEMBER 30, 2017 Source text for Eikon: Further company coverage:", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T22:22:00.000+02:00", "crawled": "2018-02-14T16:38:49.006+02:00", "highlightTitle": ""}